Patents Assigned to SPIXIA BIOTECHNOLOGY AB
  • Chimeric MOMP antigen
    Patent number: 8735543
    Abstract: The present invention regards polypeptides capable of eliciting an immunological response that is protective against Chlamydia trachomatis. The polypeptide comprises a first amino acid sequence which has at least 90% homology with the amino acid sequence according to SEQ ID NO: 1 and a second amino acid sequence which has at least 90% homology with the amino acid sequence according to SEQ ID NO: 2. Furthermore, production of these polypeptides and pharmaceutical compositions comprising them are also provided.
    Type: Grant
    Filed: May 27, 2011
    Date of Patent: May 27, 2014
    Assignee: Spixia Biotechnology AB
    Inventors: Sören Andersson, Åke Strid
  • CHIMERIC MOMP ANTIGEN
    Publication number: 20130156805
    Abstract: The present invention regards polypeptides capable of eliciting an immunological response that is protective against Chlamydia trachomatis. The polypeptide comprises a first amino acid sequence which has at least 90% homology with the amino acid sequence according to SEQ ID NO: 1 and a second amino acid sequence which has at least 90% homology with the amino acid sequence according to SEQ ID NO: 2. Furthermore, production of these polypeptides and pharmaceutical compositions comprising them are also provided.
    Type: Application
    Filed: May 27, 2011
    Publication date: June 20, 2013
    Applicant: SPIXIA BIOTECHNOLOGY AB
    Inventors: Sören Andersson, Åke Strid